Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1976 1
1977 2
1978 3
1979 4
1980 2
1981 4
1982 6
1983 1
1984 1
1985 9
1986 5
1987 4
1988 4
1989 3
1990 4
1991 7
1992 3
1993 12
1994 5
1995 7
1996 11
1997 18
1998 10
1999 14
2000 21
2001 32
2002 35
2003 33
2004 46
2005 47
2006 56
2007 49
2008 66
2009 77
2010 74
2011 103
2012 96
2013 106
2014 102
2015 111
2016 116
2017 120
2018 115
2019 133
2020 175
2021 162
2022 158
2023 174
2024 161
2025 168
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,358 results

Results by year

Filters applied: . Clear all
Page 1
Proteome-scale discovery of protein degradation and stabilization effectors.
Poirson J, Cho H, Dhillon A, Haider S, Imrit AZ, Lam MHY, Alerasool N, Lacoste J, Mizan L, Wong C, Gingras AC, Schramek D, Taipale M. Poirson J, et al. Among authors: lam mhy. Nature. 2024 Apr;628(8009):878-886. doi: 10.1038/s41586-024-07224-3. Epub 2024 Mar 20. Nature. 2024. PMID: 38509365
Commentary.
Kabbani LS, Lam MT. Kabbani LS, et al. Among authors: lam mt. Ann Vasc Surg. 2022 Aug;84:405. doi: 10.1016/j.avsg.2022.02.001. Epub 2022 Mar 4. Ann Vasc Surg. 2022. PMID: 35248741 No abstract available.
Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group.
Salem R, Padia SA, Lam M, Chiesa C, Haste P, Sangro B, Toskich B, Fowers K, Herman JM, Kappadath SC, Leung T, Sze DY, Kim E, Garin E. Salem R, et al. Among authors: lam m. Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):328-343. doi: 10.1007/s00259-022-05956-w. Epub 2022 Sep 17. Eur J Nucl Med Mol Imaging. 2023. PMID: 36114872 Free PMC article.
Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade.
Hooper AT, Marquette K, Chang CB, Golas J, Jain S, Lam MH, Guffroy M, Leal M, Falahatpisheh H, Mathur D, Chen T, Kelleher K, Khandke K, Muszynska E, Loganzo F, Rosfjord E, Lucas J, Kan Z, Subramanyam C, O'Donnell C, Neri D, Gerber HP, May C, Sapra P. Hooper AT, et al. Among authors: lam mh. Mol Cancer Ther. 2022 Sep 6;21(9):1462-1472. doi: 10.1158/1535-7163.MCT-22-0099. Mol Cancer Ther. 2022. PMID: 35793468 Free PMC article.
NIS-Seq enables cell-type-agnostic optical perturbation screening.
Fandrey CI, Jentzsch M, Konopka P, Hoch A, Blumenstock K, Zackria A, Maasewerd S, Lovotti M, Lapp DJ, Gohr FN, Suwara P, Świeżewski J, Rossnagel L, Gobs F, Cristodaro M, Muhandes L, Behrendt R, Lam MC, Walgenbach KJ, Bald T, Schmidt FI, Latz E, Schmid-Burgk JL. Fandrey CI, et al. Among authors: lam mc. Nat Biotechnol. 2025 Aug;43(8):1337-1347. doi: 10.1038/s41587-024-02516-5. Epub 2024 Dec 19. Nat Biotechnol. 2025. PMID: 39702735 Free PMC article.
2,358 results